| scholarly article | Q13442814 |
| P50 | author | Ralph Steinman | Q105494 |
| Mark J Cameron | Q88493161 | ||
| Christine Trumpfheller | Q115705829 | ||
| Marina Caskey | Q54438095 | ||
| P2093 | author name string | Andres M Salazar | |
| Sarah J Schlesinger | |||
| Li Pan | |||
| François Lefebvre | |||
| Abdelali Filali-Mouhim | |||
| Elias K Haddad | |||
| Gaëlle Breton | |||
| Irina Shimeliovich | |||
| Jean-Philippe Goulet | |||
| Rafick P Sékaly | |||
| Angela Duque-Alarcon | |||
| Annette Nelkenbaum | |||
| Sarah Pollak | |||
| P2860 | cites work | Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming | Q63952505 |
| A pathway analysis of poly(I:C)-induced global gene expression change in human peripheral blood mononuclear cells | Q82917067 | ||
| Bioconductor: open software development for computational biology and bioinformatics | Q21194861 | ||
| Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses | Q24602140 | ||
| A diverse range of gene products are effectors of the type I interferon antiviral response | Q24626018 | ||
| Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action | Q24672548 | ||
| Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques | Q27317212 | ||
| Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses | Q27487514 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 | Q27860854 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| Adjusting batch effects in microarray expression data using empirical Bayes methods | Q29614937 | ||
| Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans | Q29616204 | ||
| A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma | Q33390586 | ||
| Dissecting interferon-induced transcriptional programs in human peripheral blood cells | Q33546362 | ||
| Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity | Q34491896 | ||
| Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. | Q34624625 | ||
| Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo | Q34666875 | ||
| Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients | Q35116211 | ||
| Inferences, questions and possibilities in Toll-like receptor signalling | Q35829752 | ||
| Vaccine Adjuvants: Putting Innate Immunity to Work | Q36168232 | ||
| Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection | Q36402851 | ||
| Translating innate immunity into immunological memory: implications for vaccine development | Q36404657 | ||
| Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses | Q36500879 | ||
| Inflammasome recognition of influenza virus is essential for adaptive immune responses | Q37061831 | ||
| Vaccines: correlates of vaccine-induced immunity | Q37193062 | ||
| Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant | Q37273249 | ||
| New horizons in adjuvants for vaccine development | Q37342049 | ||
| Inflammasomes: guardians of cytosolic sanctity | Q37361455 | ||
| The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants. | Q37702152 | ||
| Regulation of inflammasome activity. | Q37750913 | ||
| Vaccines and the future of human immunology | Q37804529 | ||
| Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. | Q44550766 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| P304 | page(s) | 2357-2366 | |
| P577 | publication date | 2011-11-07 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans | |
| P478 | volume | 208 |
| Q40375946 | A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects |
| Q38605090 | A Plant-Derived Nucleic Acid Reconciles Type I IFN and a Pyroptotic-like Event in Immunity against Respiratory Viruses |
| Q40844843 | A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract |
| Q38926456 | A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile |
| Q34287659 | Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection |
| Q42248543 | Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. |
| Q64253147 | Adenosine deaminase-1 delineates human follicular helper T cell function and is altered with HIV |
| Q37372321 | Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures |
| Q38053737 | Adjuvants in influenza vaccines |
| Q38733975 | Advances in Antiviral Therapies Targeting Toll-like Receptors |
| Q63246270 | Advances in mRNA Vaccines for Infectious Diseases |
| Q91322503 | An RNA toolbox for cancer immunotherapy |
| Q40375320 | An appreciation of Ralph Marvin Steinman (1943–2011) |
| Q38692859 | An immunogenic personal neoantigen vaccine for patients with melanoma |
| Q35183935 | Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling |
| Q36945969 | CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice |
| Q38853141 | CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes |
| Q54385315 | Cancer Vaccines in Ovarian Cancer: How Can We Improve? |
| Q34735203 | Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells |
| Q37083610 | Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells |
| Q33909362 | Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity. |
| Q33889105 | Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity |
| Q41812228 | Complete Dependence on IRAK4 Kinase Activity in TLR2, but Not TLR4, Signaling Pathways Underlies Decreased Cytokine Production and Increased Susceptibility to Streptococcus pneumoniae Infection in IRAK4 Kinase–Inactive Mice |
| Q41621228 | Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo. |
| Q92350341 | Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1/Th2 response |
| Q37963951 | Decisions About Dendritic Cells: Past, Present, and Future |
| Q86763009 | Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo |
| Q38198870 | Democratizing systems immunology with modular transcriptional repertoire analyses |
| Q37293439 | Dendritic cell derived cytokines in human natural killer cell differentiation and activation |
| Q35680858 | Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity |
| Q38800011 | Designing therapeutic cancer vaccines by mimicking viral infections |
| Q91912074 | Development of Drugs Based on High-Polymeric Double-Stranded RNA for Antiviral and Antitumor Therapy |
| Q37042563 | Development of prophylactic vaccines against HIV-1. |
| Q38597260 | EBV Infection of Mice with Reconstituted Human Immune System Components |
| Q27303669 | Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates |
| Q37584926 | Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways. |
| Q34540207 | Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge |
| Q38888354 | Extracellular poly(ADP-ribose) is a pro-inflammatory signal for macrophages |
| Q40333429 | GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth. |
| Q37603557 | Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination |
| Q39403308 | Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119. |
| Q33659782 | Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy |
| Q39863954 | Highly immunostimulatory RNA derived from a Sendai virus defective viral genome |
| Q37270293 | Highly multiplexed quantitation of gene expression on single cells |
| Q28540195 | Human genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in Type-I interferon response |
| Q36350381 | Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C. |
| Q42106951 | Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors. |
| Q27023844 | Hypothesis driven development of new adjuvants: short peptides as immunomodulators |
| Q27016633 | Immune response to vaccine adjuvants during the first year of life |
| Q37546314 | Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents |
| Q37469633 | Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica Serovar Typhimurium flagellin |
| Q42378527 | Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy |
| Q64071120 | Immunotherapeutic effects of intratumoral nanoplexed poly I:C |
| Q40868178 | Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis |
| Q58553701 | In vivo cancer vaccination: Which dendritic cells to target and how? |
| Q35768825 | Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity |
| Q37458109 | Increased abundance of ADAM9 transcripts in the blood is associated with tissue damage |
| Q40908427 | Indirect Toll-like receptor 5-mediated activation of conventional dendritic cells promotes the mucosal adjuvant activity of flagellin in the respiratory tract |
| Q40441002 | Inflammation enhances the vaccination potential of CD40-activated B cells in mice |
| Q30367695 | Influenza vaccines: a moving interdisciplinary field. |
| Q90697829 | Inhibition of PI3Kδ Enhances Poly I:C-Induced Antiviral Responses and Inhibits Replication of Human Metapneumovirus in Murine Lungs and Human Bronchial Epithelial Cells |
| Q37713902 | Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. |
| Q38991015 | Innate immune mediators in cancer: between defense and resistance |
| Q42268758 | Innate immune pathways in afferent lymph following vaccination with poly(I:C)-containing liposomes. |
| Q39041026 | Innate immune signaling and regulation in cancer immunotherapy |
| Q28083788 | Interferons and viruses: an evolutionary arms race of molecular interactions |
| Q35488175 | Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins |
| Q34510913 | Intranasal Administration of dsRNA Analog Poly(I:C) Induces Interferon-α Receptor-Dependent Accumulation of Antigen Experienced T Cells in the Airways |
| Q36363186 | Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections |
| Q100416706 | Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancer |
| Q36315857 | Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C |
| Q40357186 | Learning vaccinology from viral infections |
| Q36385484 | Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines |
| Q36508191 | MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study |
| Q42179388 | Maternal immune activation in nonhuman primates alters social attention in juvenile offspring |
| Q37377169 | MicroRNA Transcriptome of Poly I:C-Stimulated Peripheral Blood Mononuclear Cells Reveals Evidence for MicroRNAs in Regulating Host Response to RNA Viruses in Pigs |
| Q37073076 | Minicircle DNA is Superior to Plasmid DNA in Eliciting Antigen-specific CD8+ T-cell Responses |
| Q33821633 | Modulation of innate immune signaling by the secreted form of the West Nile virus NS1 glycoprotein |
| Q38029860 | Mucosal IgA responses in influenza virus infections; thoughts for vaccine design |
| Q30364623 | Mucosal immunization and adjuvants. |
| Q38071909 | Multi-step regulation of interferon induction by hepatitis C virus. |
| Q37139374 | Mutated BCR-ABL generates immunogenic T-cell epitopes in CML patients |
| Q90479627 | Myeloid Cells Enriched for a Dendritic Cell Population From People Living With HIV Have Altered Gene Expression Not Restored by Antiretroviral Therapy |
| Q35836140 | Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. |
| Q26800283 | New approaches to understanding the immune response to vaccination and infection |
| Q37384717 | New generation of dendritic cell vaccines |
| Q34999938 | Novel drugs targeting Toll-like receptors for antiviral therapy |
| Q38021271 | Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination |
| Q37421190 | Overview on poly(ADP-ribose) immuno-biomedicine and future prospects |
| Q38113370 | Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant |
| Q35167156 | Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors |
| Q42188915 | Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine |
| Q64063100 | Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial |
| Q27324710 | PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo |
| Q38305650 | Potential approaches for more successful dendritic cell-based immunotherapy |
| Q59350175 | PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials |
| Q41148825 | Preliminary evidence of neuropathology in nonhuman primates prenatally exposed to maternal immune activation. |
| Q40220037 | Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes |
| Q89606726 | RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness |
| Q38111853 | RNA: The new revolution in nucleic acid vaccines |
| Q27025822 | Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants |
| Q33886345 | Selection of Reference Genes for Gene Expression Studies in Porcine Whole Blood and Peripheral Blood Mononuclear Cells under Polyinosinic:Polycytidylic Acid Stimulation |
| Q59349658 | Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses |
| Q38255634 | Self-replicating alphavirus RNA vaccines. |
| Q97533909 | Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer |
| Q47097375 | Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles |
| Q27335125 | Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity |
| Q30540603 | Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines |
| Q41475520 | TAMable tumor-associated macrophages in response to innate RNA sensing |
| Q41997055 | TLR Agonists as Adjuvants for Cancer Vaccines. |
| Q64069937 | TLR3 Activation of Intratumoral CD103 Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity |
| Q40204511 | TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus |
| Q36212034 | TLR3-Induced Maturation of Murine Dendritic Cells Regulates CTL Responses by Modulating PD-L1 Trafficking |
| Q36373374 | TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis |
| Q34667534 | TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant |
| Q37683966 | Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver. |
| Q27312070 | Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity |
| Q39432584 | Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses. |
| Q38081981 | Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer |
| Q64039369 | Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease |
| Q36245506 | Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice |
| Q39012036 | The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease |
| Q37042237 | The host STING pathway at the interface of cancer and immunity |
| Q57462243 | Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial |
| Q31152190 | Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation |
| Q47789519 | Towards personalized, tumour-specific, therapeutic vaccines for cancer. |
| Q51584617 | Transcriptional profile in afferent lymph cells following vaccination with liposomes incorporating CpG. |
| Q36867885 | Transcriptomic Analysis Identifies Candidate Genes and Gene Sets Controlling the Response of Porcine Peripheral Blood Mononuclear Cells to Poly I:C Stimulation |
| Q38570333 | Translating nucleic acid-sensing pathways into therapies |
| Q35739585 | Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis |
| Q36016455 | Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity |
| Q38976179 | Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists |
| Q41782819 | Unraveling the molecular pathways of DNA-methylation inhibitors: human endogenous retroviruses induce the innate immune response in tumors |
| Q42184808 | Vaccination with liposomal poly(I:C) induces discordant maturation of migratory dendritic cell subsets and anti-viral gene signatures in afferent lymph cells |
| Q42699604 | Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite |
| Q38259510 | Vaccine adjuvant uses of poly-IC and derivatives |
| Q33850483 | Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo |
| Q59359933 | Virus-derived immunostimulatory RNA induces type I IFN-dependent antibodies and T-cell responses during vaccination |
| Q46660168 | Will Systems Biology Deliver Its Promise and Contribute to the Development of New or Improved Vaccines? From Data to Understanding through Systems Biology |
| Q34364808 | mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. |
Search more.